Figure 3From: The effects of telbivudine in late pregnancy to prevent intrauterine transmission of the hepatitis B virus: a systematic review and meta-analysis Forest plots of telbivudine vs. control on infant HBsAg seropositivity at age 6–12 months. Back to article page